scholarly journals ANALYSIS OF A TWO LACTATION TARGET ANIMAL SAFETY STUDY OF SOMIDOBOVE SUSTAINED RELEASE INJECTION IN MULTIPAROUS DAIRY COWS

Author(s):  
L. V. Tonkinson ◽  
R. P. Basson ◽  
R. K. McGuffey ◽  
A. Deldar ◽  
L. Fisher
2016 ◽  
Vol 187 ◽  
pp. 146-150 ◽  
Author(s):  
Simin Khorsandi ◽  
Ahmad Riasi ◽  
Mohammad Khorvash ◽  
Saeid Ansari Mahyari ◽  
Farhad Mohammadpanah ◽  
...  

2017 ◽  
Vol 08 (06) ◽  
Author(s):  
David Xiang Yu ◽  
Zhiyong He ◽  
Colin Pouton ◽  
Frederic J Hoerr ◽  
Zhi cheng Xiao

Author(s):  
D J Roberts ◽  
R J Wells ◽  
D N Logue ◽  
A G Buchanan

Farmers are receiving a price incentive to produce more milk during the summer months. Bovine somatotropin (BST) could be used as a means of increasing milk yield from late winter/spring calving cows during the summer months. However, most of the research work with BST has been with housed cattle on winter feeding systems. The objective of this experiment was to evaluate the use of BST with grazing cattle supplemented with silage as a buffer feed.Thirty-six January to March calving multiparous Friesian dairy cows were allocated to 4 treatments: CG - Control/Grazing, TG - Treated/Grazing, CB - Control/Buffer fed, TB - Treated/Buffer fed. The treated cattle were given 640 mg of recombinantly derived bovine somatotropin (Somidobove Elanco Products Limited) in a sustained release formulation at 28 day intervals. The treatment period at grass lasted for 8 weeks from 18 August 1988. The cattle were then housed for a further 8 weeks in 2 groups of sixteen cows (with one block of cows omitted from the experiment).


2018 ◽  
Vol 30 (1) ◽  
pp. 146
Author(s):  
M. P. Bottino ◽  
L. A. C. L. DaSilva ◽  
L. M. S. Simoes ◽  
G. Santos ◽  
I. Y. H. Martinez ◽  
...  

The objective was to compare a pre-synchronization protocol by induction of a dominant follicle using a progesterone intravaginal device before an Ovsynch protocol (Presynch) with Double-Ovsynch in lactating dairy cows. Lactating Bos indicus × Bos taurus crossbred cows (n = 440) were randomly allocated to 1 of 2 treatments (all IM injections): (1) Double-Ov (n = 228): GnRH (Day –17), prostaglandin F2α (PGF2α) 7 days later (Day –10) and gonadotropin-releasing hormone (GnRH) 3 days later (Day –7) followed by an Ovsynch protocol 7 days later (GnRH on Day 0, PGF2α on Day 7, GnRH on Day 9); (2) Presynch (n = 212): insertion of a sustained release progesterone intravaginal device (Day –10), 10 days later (Day 0), an Ovsynch protocol was initiated with progesterone device withdrawal on Day 7. All cows were artificially inseminated 15 to 20 h after the second GnRH injection of the Ovsynch protocol and were pregnancy checked by ultrasonography 30 and 60 days later. On a subsample (n = 102), ultrasonography was performed on Days 0, 7, 9, and 24 of the experimental period. On another subsample (n = 42), blood samples for progesterone analysis were taken on Days 0, 7, and 24. There were no differences between pre-synchronization methods on synchronization parameters [presence of a follicle >12 mm on D0, Double-Ov 94.2% (49/52) and Presynch 92.0% (46/50); P = 0.66], follicular diameter on the 1st GnRH (Double-Ov 17.2 ± 0.7 mm and Presynch 18.6 ± 0.9 mm; P = 0.28), ovulation rate to the 1st GnRH [Double-Ov 86.3% (44/51) and Presynch 81.2% (39/48); P = 0.50], synchronization rate [Double-Ov 84.6% (44/52) and Presynch 86.0% (43/50); P = 0.84], follicular diameter on the 2nd GnRH (Double-Ov 17.5 ± 0.6 mm and Presynch 18.0 ± 0.5 mm; P = 0.48), ovulation rate to the 2nd GnRH [Double-Ov 90.9% (40/44) and Presynch 86.0% (37/43); P = 0.48] and CL diameter on Day 24 (Double-Ov 27.9 ± 0.7 mm and Presynch 29.4 ± 0.9 mm; P = 0.19). Corpus luteum presence on Day 0 was different (P = 0.03) between treatments [Double-Ov 57.7% (30/52) and Presynch 36.0% (18/50)]. Moreover, there was no difference (P = 0.85) between pregnancy rates on Day 30 [Double-Ov 39.0% (89/228) and Presynch 40.1% (85/212)] or Day 60 after AI [Double-Ov 34.8% (79/227) and Presynch 38.7% (82/212); P = 0.41] and gestational loss between 30 and 60 days after AI [Double-Ov 7.9% (7/88) and Presynch 3.5% (3/85); P = 0.13]. Proportion of cows with P4 <1 ng mL−1 on Day 0 was similar between treatments [Double-Ov 13.6% (3/22) v. Presynch 5.0% (1/20); P = 0.37]. Likewise, the proportion of cows with P4 >1 ng mL−1 on Day 7 [Double-Ov 77.3% (17/22) v. Presynch 95.0% (19/20); P = 0.14] and P4 concentration on Day 24 (Double-Ov 4.7 ± 0.6 v. P4-Ov 5.9 ± 0.9; P = 0.84) were similar between treatments. In conclusion, pre-synchronization by induction of follicular persistence using a sustained-release progesterone device before Ovsynch yielded similar results to the Double-Ovsynch protocol on follicular development and regression patterns and on the fertility of lactating dairy cows.


1991 ◽  
Vol 71 (2) ◽  
pp. 343-353 ◽  
Author(s):  
Guillermo F. Gallo ◽  
Elliot Block

Three trials were conducted to determine the effects of recombinant bovine somatotropin (rbST) on reproductive functions of lactating Holstein dairy cows. In Trial 1, 49 cows were used to investigate the effects of 0, 320 or 640 mg of rbST in a sustained-release formulation injected every 28 d on plasma progesterone (P4) concentration during estrous cycles. Total P4 area and P4 mean were increased (P < 0.05) in rbST-treated cows during the 1st and 2nd detected estrous cycle post-rbST injection. Maximum P4 value, slope of the P4 decline and length of cycles were not affected by rbST treatment. In Trial 2, 56 cows were used to investigate the effects of 0, 320, 640 and 960 mg of rbST in a sustained-release preparation injected every 28 d on plasma P4 concentration from weeks 1 to 34 of pregnancy. Mean P4 was increased (P = 0.08) in rbST-treated cows proportionally to the rbST dose received. In Trial 3, 18 cows were used to investigate the effects of 0 or 25 mg d−1 of rbST injected from days 3 to 15 postpartum (pp) on the gonadotropin-releasing hormone (GnRH) induced luteinizing hormone (LH) response curve at 14 d pp. Total area under the LH curve and LH peak value were increased (P < 0.05) in rbST-treated cows, but LH baseline and time to LH peak were not different among groups. Cows receiving rbST were in a more negative energy balance due to higher milk production. In summary, long-term administration of rbST increased the concentration of plasma progesterone during the first two estrous cycles post-treatment and during pregnancy, and enhanced the GnRH-induced LH response at 14 d pp. Key words: Bovine somatotropin, GnRH-LH induction, progesterone, estrous cycle, pregnancy


Sign in / Sign up

Export Citation Format

Share Document